Reaction
Intracranial Mass reporting signals
As of the last recalculation, Intracranial Mass appears in 930 FAERS reports alongside 19 co-occurring drug terms. The strongest observed disproportionality signal is GANCICLOVIR (PRR 26.6).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Ganciclovir | 12 | 26.6 | 26.6 |
| Ganciclovir Sodium | 12 | 25.7 | 25.7 |
| Amphotericin B | 14 | 25.4 | 25.4 |
| Posaconazole Delayed-Release | 12 | 24.8 | 24.8 |
| Ado-Trastuzumab Emtansine | 8 | 21.4 | 21.4 |
| Nebivolol | 14 | 20.0 | 20.0 |
| Posaconazole | 14 | 19.6 | 19.6 |
| Cefepime | 11 | 17.4 | 17.4 |
| Alteplase | 11 | 16.6 | 16.6 |
| Voriconazole Injection | 15 | 15.7 | 15.7 |
| Cefepime Hydrochloride | 11 | 15.5 | 15.5 |
| Lapatinib | 9 | 13.1 | 13.1 |
| Dabrafenib | 12 | 12.9 | 12.9 |
| Pazopanib Hydrochloride | 15 | 12.6 | 12.6 |
| Trametinib | 12 | 11.2 | 11.3 |
| Temozolomide | 9 | 9.6 | 9.6 |
| Vemurafenib | 5 | 9.4 | 9.4 |
| Pertuzumab | 11 | 9.2 | 9.2 |
| Esketamine Hydrochloride | 3 | 3.8 | 3.8 |